CXCL9 Protéine

N° du produit ABIN935628

Cette protéine Recombinant CXCL9 est exprimée dans Escherichia coli (E. coli).

Aperçu rapide pour CXCL9 Protéine (ABIN935628)

Antigène: CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))

Type de proteíne: Recombinant

Activité biologique: Active

Origine: Humain

Source: Escherichia coli (E. coli)

Pureté: > 98 % pure

Détail du produit

Séquence: TPVVRKGRCS CISTNQGTIH LQSLKDLKQF APSPSCEKIE IIATLKNGVQ TCLNPDSADV KELIKKWEKQ VSQKKKQKNG KKHQKKKVLK VRKSQRSRQK KTT

Attributs du produit: Purified recombinant Human MIG protein
Expression System: E.coli
Bioactivity: Determined by its ability to chemoattract human peripheral blood T lymphoytes using a concentration range of 10.0-100.0 ng/mL.

niveau d'endotoxine: < 0.1 ng per µg (1 EU/µg).

Information d'application

Indications d'application: Each Investigator should determine their own optimal working dilution for specific applications.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Reconstitute in water to a concentration of 0.1-1.0 mg/mL. The solution canthen be diluted into other aqueous buffers.

Buffer: Supplied lyophilized with no additives.

Agent conservateur: Without preservative

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: RT/-20 °C

Détail du antigène

Antigène: CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))

Autre désignation: MIG

Sujet: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on Mouse cells.
Alternative Names: CXCL9 protein, Monokine Induced by Interferon-gamma protein

Poids moléculaire: 11.7 kDa